ACOG/LinkedIn
Oct 15, 2025, 09:08
ACOG Publishes Clinical Update on Postpartum Zuranolone Therapy
American College of Obstetricians and Gynecologists (ACOG) shared a post on LinkedIn:
“ACOG’s latest Clinical Practice Update makes finding the guidance you need on treating depression with zuranolone during the postpartum period easier to find, understand, and put into practice, with clear recommendations, implementation considerations, and more. The guidance also answers questions about clinical scenarios that may arise when considering zuranolone and includes newly available data about concentrations of zuranolone in human milk. Read the guidance.”
-
Apr 30, 2026, 02:02Sandro Esteves and Marcos Meseguer: From Biology to Bedside in Male Infertility
-
Apr 29, 2026, 12:34Inclusive Guidance for People Exploring Donor Conception – London Sperm Bank
-
Apr 29, 2026, 12:07International Donor Conception Awareness Day – HFEA
-
Apr 29, 2026, 11:56Infertility Treatment Access as NIAW2026 Comes to a Close – ASRM
-
Apr 29, 2026, 11:31RCOG Opens New Webinar Series to Support O and G Surgical Skills Training
-
Apr 29, 2026, 11:22Pauline Saint Martin: Victims of Violence, Screening and Health Consequences in Focus in New Webinar
-
Apr 29, 2026, 10:56Christopher Robinson: Isolated Severe Systolic Hypertension During Delivery Admission and Maternal Outcomes
-
Apr 29, 2026, 10:49Risks, Costs and Evidence Behind Fertility Add-Ons – HFEA
-
Apr 29, 2026, 10:29Estradiol Levels and Embryo Development in IVF – RBMO